Inferior Vena Cava Filters (IVCF) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Inferior Vena Cava Filters (IVCF) Market Report Overview
The inferior vena cava filters (IVCF) market was valued at $128 million in 2023 and will decline at a CAGR of more than 1% during 2023-2033. IVCF is a metallic device used to prevent blood clots from traveling to the lungs. The filter is inserted inside a large vein called the inferior vena cava (IVC). IVC filter traps blood clots before they reach the lungs.
IVCF Market Outlook 2023-2033 ($ Million)
For More Detailed Insights on the IVCF Market Forecast,
Download a Free Sample Report
The IVCF market research report explains the market behavior, which will help identify quantitative market trends within the cardiovascular devices therapeutic area. The report has extensively covered regional-wise quantitative data, highlighting the number of IVCFs across labs, which will help in identifying untapped market opportunities. The model also discusses the detailed impact of COVID-19 on the IVCF market for 2020 and beyond.
Market Size (2023) | $128 million |
CAGR(2023-2033) | <(1)% |
Historic Period | 2015-2023 |
Forecast Period | 2023-2033 |
Key Segments |
|
Key Regions |
|
Key Companies |
|
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
IVCF Market Dynamics
The IVCF market is currently experiencing a declining trend and GlobalData expects that the trend will continue until the issues associated with the device (including the low retrieval rate, device complications, and pending lawsuits against the manufacturers) are resolved and the effectiveness of the device in Venous Thromboembolism (VTE) prophylaxis is proven. However, the non-availability of alternatives for anticoagulants has ensured the continued demand for the device. Innovations, such as the bioconvertible IVC filter Sentry, have a lower risk of complications when compared to the other filters. This will have a positive impact on the vena cava filter market and the market is likely to stabilize in the future.
IVCF Market Segmentation by Regions
The key regions in the IVCF market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, North America had the largest share of the IVCF market. However, the ongoing lawsuits against IVCF manufacturers are causing the regional market to decline. Additionally, the growing awareness about the complications associated with the IVCF device further enhances the market decline.
IVCF Market Analysis by Regions, 2023 (%)
Buy the Full Report For More Regional Insights into the IVCF Market
Download a Free Sample Report
IVCF Market Segmentation by Segments
The key segments in the IVCF market are IVCF retrieval devices, permanent IVCF, and retrievable IVCF. In 2023, the retrievable IVCF segment dominated the IVCF market. The retrievable filters can be removed once the risk of recurrence or development of VTE is reduced. The retrievable filter is further classified into two types: optional retrievable IVCF and temporary retrievable IVCF.
IVCF Market Analysis by Segments, 2023 (%)
For More Segment-Wise Insights into the IVCF Market
Download a Free Sample Report
IVCF Market – Competitive Landscape
A few of the leading companies in the IVCF market are :
- Mermaid Medical A/S
- Becton Dickinson and Co
- LifeTech Scientific Corp
- ALN implants chirurgicaux
- B. Braun SE
In 2023, Mermaid Medical A/S accounted for the highest IVCF market share.
IVCF Market Analysis by Companies, 2023 (%)
Buy the Full Report to Know More About Leading IVCF Market Players
Download a Free Sample Report
Segments Covered in this Report
IVCF Regional Outlook ($ Million, 2015-2033)
- Asia-Pacific
- Europe
- Middle East and Africa
- North America
- South and Central America
IVCF Segment Outlook ($ Million, 2015-2033)
- IVCF Retrieval Devices
- Permanent IVCF
- Retrievable IVCF
- Optional Retrievable IVCF
- Temporary Retrievable IVCF
Key Inclusions of the market model are:
Currently marketed IVCF market and evolving competitive landscape:
- Insightful review of the key industry trends.
- Annualized total IVCF market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional, and Country level market specific insights:
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the IVCF market.
- Competitive dynamics insights and trends provided for the IVCF market.
Get an in-depth understanding of consumer behavior through the market access segment and the overview of the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, the report helps determine market trends through real-world data sources including government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Mermaid Medical A/S, Becton Dickinson and Co, Shandong Weigao Group Medical Polymer Co Ltd, Cook Group Inc, Cardinal Health Inc, B. Braun SE, LifeTech Scientific Corporation, Merit Medical Systems Inc, ALN implants chirurgicaux, Boston Scientific Corp, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. The model will benefit the following stakeholders:
- CMO executives must have a deep understanding of the IVCF marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives must understand crucial components of the supply base to make decisions about supplier selection and management.
- Private equity investors who need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
- Understand the impact of COVID-19 on IVCF.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving IVCF.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the IVCF market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific IVCF market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Becton Dickinson and Co
Argon Medical Devices Inc
Cook Group Inc
Cardinal Health Inc
B. Braun Melsungen AG
LifeTech Scientific Corp
Merit Medical Systems Inc
ALN implants chirurgicaux
Boston Scientific Corp
Others
Frequently asked questions
-
What was the IVCF market size in 2023?
The IVCF market size was $128 million in 2023.
-
What will the IVCF market growth rate be during the forecast period?
The IVCF market will decline at a CAGR of more than 1% during 2023-2033.
-
Which region held the largest share of the IVCF market in 2023?
North America accounted for the largest share of the IVCF market in 2023.
-
Which segment held the largest share of the IVCF market in 2023?
In 2023, the retrievable IVCF segment held the largest share of the IVCF market share.
-
Which are the leading companies operating in the IVCF market?
A few of the leading companies in the IVCF market are Mermaid Medical A/S, Becton Dickinson and Co, LifeTech Scientific Corp, ALN implants chirurgicaux, and B. Braun SE, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.